BRENDALYNE TAMBA: Open Payments
NPI 1053925107 · WINDER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 17 payments from 9 companies in 2025. Trend: 2023 $381 · 2024 $584 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| AKEBIA THERAPEUTICS INC | 3 | $81 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Fresenius USA Marketing, Inc. | 2 | $47 |
| Travere Therapeutics, Inc. | 2 | $33 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| KYOWA KIRIN, INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Vantive US Healthcare LLC | 1 | $14 |
Products named: JYNARQUE, Vafseo, VELPHORO, Vanrafia, Fabhalta, PURIFIED CORTROPHIN GEL, CRYSVITA, FARXIGA.
Industry payments across GA — which companies pay providers there.
